Macy's Inc (M) Stock News

Warren Buffett's market valuation indicator (market-cap-to-GDP ratio) is currently at 233%, well above his 200% warning threshold, suggesting stocks are trading at historically expensive levels. While this doesn't guarantee an imminent crash, history shows such valuations preceded the dot-com bubble (49% S&P 500 decline) and 2022 correction (25% decline). However, today's AI leaders have stronger fundamentals than dot-com era companies, and investors should focus on quality companies with competitive advantages rather than timing the market.

A class action lawsuit has been filed against Millrose Properties, Inc. (NYSE: MRP) alleging that the company failed to disclose material information to investors during the Class Period (February 7, 2025 - October 2, 2026). The complaint alleges that Millrose misrepresented its business objectives, failed to disclose tenant lease agreements, and purchased $200 million in properties from Lennar Corporation that were leased at a loss. Investors who suffered losses are encouraged to join the case with a lead plaintiff deadline of December 8, 2026.

Greg Abel, Berkshire Hathaway's new CEO, has concentrated the portfolio into 5 stocks representing 69% of holdings, down from 42 to 29 total positions. Abel has aggressively increased Alphabet holdings from 2% to 9.4% in just one year, similar to how Warren Buffett built Apple into the largest position. Despite high capital expenditures, Alphabet's attractive 16x P/E ratio and $514 billion cloud backlog make it an appealing investment during the AI boom.

E-Power Inc.'s joint venture Sunrise Guizhou received RMB 110 million (approximately US$16.5 million) of a RMB 200 million capital increase from an investment fund, valuing the company at RMB 2.0 billion post-money on a fully funded basis. The funds will support capacity expansion, R&D, and new projects for the anode materials business. E-Power's stake in Sunrise Guizhou decreased from 39.35% to 37.09% following the registration.

While Intel's foundry business is showing growth momentum with recent government and Nvidia investments, TSMC remains the superior value investment. Intel's foundry division operates at a 36% loss with a forward P/E of 44x, compared to TSMC's 59% operating margin and 18x P/E ratio. Despite Intel's turnaround narrative gaining market attention, TSMC's profitability and valuation make it the more attractive choice for investors.

State Street's XPH and Simplify's PINK offer two distinct approaches to healthcare investing. XPH provides lower-cost, passive pharmaceutical exposure with stronger recent returns (30.5% vs 18.3%), while PINK offers active, broader healthcare management with higher dividend yield (0.8% vs 0.4%) and lower volatility. PINK uniquely donates its management fees to breast cancer research. XPH suits cost-conscious pharma investors, while PINK appeals to those seeking active management and philanthropic impact.

Coca-Cola shares have reached record highs with a 35% rally in 2026, but the article advises waiting for a pullback rather than buying now. The stock's valuation metrics—including a trailing P/E ratio of 28 and price-to-sales ratio above 8—have reached unsustainable levels. While the company benefits from defensive positioning as investors seek safety, the limited upside (only 2% to analyst targets) and multi-year low dividend yield of 2.2% make it a less attractive entry point compared to other dividend stocks.

High inflation and competition for investor dollars are helping keep longer-term interest rates elevated, economists say.

AS Tallinna Sadam signed an unsecured loan agreement with Swedbank for €50 million over 5 years to refinance maturing bonds. The loan will be drawn in full on October 26, 2026, with repayment due October 26, 2031. The financing covers bonds totaling €50.4 million at maturity.

Meta Platforms is looking to raise $95 billion to fund its massive AI infrastructure buildout.

Meta's stock has fallen approximately 7-9% following three consecutive strong earnings reports in 2026, driven by investor concerns over escalating capital expenditures rather than revenue performance. Despite impressive 26% revenue growth and stable operating cash flow around $32 billion quarterly, Meta's capex has surged to $34.9 billion in Q3, pushing free cash flow negative at -$2.1 billion. The company raised its 2026 spending guidance to $135-145 billion. Trading at 19x forward earnings (market average), the analyst suggests the stock may be worth considering after the recent dip, though further declines could follow the next earnings report.

Micron Technology reported record-breaking fiscal Q4 earnings with $54.2B revenue (380% YoY growth) and 87% gross margins, yet the stock declined 20% since earnings. The sell-off reflects broader semiconductor weakness and investor concerns about AI capex sustainability, elevated valuations, and the cyclical nature of memory markets. Despite these headwinds, the author views Micron's 7x forward P/E as attractive, positioning it as a compelling buying opportunity.

Meta Platforms announced a 2-for-1 stock split effective January 2027. With 3.64 billion daily active users and its new Muse AI assistant gaining traction, Meta's market cap of $1.65 trillion could reach $3 trillion within years. Despite heavy AI infrastructure spending ($145 billion in 2026), Meta trades at a P/E of 22.1, below the Nasdaq-100's 30.2, suggesting significant upside potential.

IGSB and SMB are both short-duration bond ETFs serving different investor needs. IGSB focuses on investment-grade corporate bonds with higher yield (4.7%) and better 5-year returns (14%), while SMB targets tax-exempt municipal bonds with tax advantages. IGSB has lower costs (0.04% expense ratio) and larger assets under management ($23.5B), making it attractive for income-focused investors, whereas SMB appeals to those seeking tax efficiency.

Senseonics announced the initiation of its first-in-human clinical study for Freedom, an investigational next-generation continuous glucose monitoring (CGM) system designed to communicate directly with mobile devices without an external transmitter. Built on proven Eversense 365 technology and supported by encouraging preclinical data, Freedom aims for potential commercial launch in 2028, with a pivotal study expected to begin in 2027.

Stryker has completed its acquisition of ZuriMED, a developer of the FiberLocker System, a rotator cuff augmentation technology designed to enhance biomechanical strength in rotator cuff repairs. The acquisition expands Stryker's shoulder care capabilities and allows the company to offer innovative solutions to shoulder surgeons and specialists.

Realty Income (O), a real estate investment trust with a 5.9% dividend yield, pays monthly dividends to shareholders. A $30,000 investment at $57 per share would yield approximately $142.81 monthly ($1,714 annually). The company owns over 15,500 properties with long-term leases, maintains 98.8% occupancy, and has increased its dividend for 30+ consecutive years with 116 consecutive monthly increases.

SpaceX reported strong Q3 earnings with $14.6B in revenue and $4.4B net income, beating expectations significantly. CEO Elon Musk projected ambitious goals including 10 GW of AI compute capacity by end of 2027 and $500B-$1T annual recurring revenue. Wall Street responded positively with Citigroup placing the stock on an "upside 90-day catalyst watch" with a $240 price target, while JPMorgan Chase more than doubled its target to $500. However, the author expresses skepticism about the aggressive analyst projections given execution risks and Musk's historical track record of delays.

GE Vernova's $176 billion backlog is impressive, but investors should focus on gigawatts of gas power capacity, particularly HA-class heavy-duty gas turbines. These turbines generate $500 million in high-margin service revenue per GW over 20 years. The company expects 400 HA machines running or on contract by end of 2027, with guidance for 20-40 GW orders in the second half of 2026. Strong HA turbine orders could significantly boost the stock.

Three major law firms have filed a securities class action lawsuit against Compass, Inc. and Anywhere Real Estate Inc. on behalf of former Anywhere shareholders who exchanged their shares for Compass stock in a January 2026 merger. The complaint alleges that defendants misrepresented their regulatory compliance efforts and secretly hired Trump-connected lobbyists to circumvent standard DOJ merger review processes. Compass stock has declined over 28% since the merger closing, and the lawsuit seeks damages for affected shareholders.

Eikon Therapeutics presented updated data for EIK1001, a TLR7/8 dual-agonist, combined with pembrolizumab and chemotherapy for first-line stage 4 NSCLC at ESMO Congress. The squamous cohort showed 72% ORR and 100% DCR with 12.9-month median duration of response. The combination was well-tolerated with an adverse event profile similar to standard-of-care alone, supporting outpatient administration. The Phase 2/3 TeLuRide-008 trial is actively enrolling with interim analysis expected in 2H 2027.

Securities law firm BFA Law is investigating Cardinal Infrastructure Group (NASDAQ: CDNL) for potential securities fraud related to misrepresentations about the performance of its A.L. Grading Contractors acquisition. The company's stock dropped 36% on August 11, 2026, after reporting Q2 2026 results showing an adjusted EBITDA margin of only 12.4%, significantly below the 20%+ margin previously communicated to investors, due to increased costs and scalability issues at the acquired business.

3M is showing operational improvements under CEO Bill Brown with accelerating organic sales growth and strong new product introductions (350 NPIs expected in 2026). The company upgraded its 2026 earnings guidance and maintains an attractive valuation at 18.4x price-to-FCF. However, significant legal settlement payments of $2.6 billion in 2027 and $1.6 billion in 2028 related to PFAS contamination and combat arms earplugs litigation will pressure near-term cash flow, making patience necessary for long-term investors.

Alphabet's Google Cloud backlog reached $514 billion, demonstrating strong AI demand. However, investors should focus on cloud margins, capital expenditure efficiency, and Search revenue growth when the company reports Q3 earnings on Oct. 28, rather than the backlog figure alone. The company faces margin pressure from third-party capacity usage and massive capex spending, but its profitable advertising business and AI investments position it well long-term.

Nike stock has declined 76.5% over five years and 40% in 2026 alone. While the company remains profitable with a 4.4% dividend yield and 24 consecutive years of dividend increases, the author recommends against buying the dip until Nike demonstrates stable revenue generation rather than continued declines. The stock may appeal as an income investment once it stabilizes, but current revenue headwinds make it too risky for now.

BioNTech and DualityBio announced that their Phase 3 DYNASTY-Breast02 trial met its primary endpoint, showing statistically significant but modest improvement in progression-free survival with trastuzumab pamirtecan versus chemotherapy in HR+/HER2-low metastatic breast cancer patients. However, a higher rate of interstitial lung disease was observed, and the companies noted limited potential benefit in the current treatment landscape.

Conow, developed with Tuya Smart, has launched the Atlas 6000 AC, a 6 kWh AC-coupled home battery in Germany designed for retrofitting existing rooftop solar installations. The plug-and-play system features AI-powered energy management (Conow AIX) that optimizes energy generation, storage, and consumption while coordinating compatible smart home devices, heat pumps, and EV chargers across 3,000+ device categories and 1,000+ dynamic electricity tariff providers.

Despite concerns about elevated valuations and potential market corrections, the author argues investors shouldn't worry about crashes if they hold quality stocks long-term. The S&P 500 has gained 100% over three years, but the Shiller CAPE ratio suggests stocks are expensive. The author recommends holding quality companies and buying dips rather than timing the market, citing historical data showing recovery after downturns.

Middle East markets rebound as diplomacy fuels hopes of easing Iran hostilities  Reuters

The Nasdaq Composite dropped 694 points (2.6%) on October 22, 2026, marking its largest daily decline since June. While the stock market has rallied significantly since 2022 driven by AI infrastructure spending, historical indicators suggest elevated crash risk: the S&P 500's CAPE Ratio near 43 (vs. historical average of 17.44) and margin debt at record $1.502 trillion. However, the article emphasizes that downturns are normal and historically resolve quickly, with bull markets lasting 3.6 times longer than bear markets on average.